A notable advancement in blood sugar treatment is emerging with the introduction of tirzepatide at a dosage of 45mg. This new formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, https://dianeaelt888603.wikilinksnews.com/6911421/groundbreaking_approach_tirzepatide_45mg_for_glucose_management